PharmatrophiX
Latest round
- Series A
Last raised
- Oct 2014
Total raised
- $5.5M
Investors
- 1
About PharmatrophiX
Based in North Carolina, US, and founded in 2005 by founder Frank Longo, PharmatrophiX is engaged in developing drugs for neurodegenerative diseases and other disorders. PharmatrophiX offers disease-modifying small-molecule drugs to slow or prevent the progression of neurodegenerative diseases by targeting the underlying biological mechanisms. The company utilizes a virtual business model and focuses on drugs that promote synaptic resilience in the brain.
Who invested in PharmatrophiX
1 investor across 1 round
See all investors in PharmatrophiX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 6, 2014
Amount
$5.5M
Investors
Questions about PharmatrophiX
Who invested in PharmatrophiX?
PharmatrophiX has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PharmatrophiX raised?
PharmatrophiX has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PharmatrophiX last raise money?
PharmatrophiX's most recent round on record is a Series A, in Oct 2014.
What does PharmatrophiX do?
Based in North Carolina, US, and founded in 2005 by founder Frank Longo, PharmatrophiX is engaged in developing drugs for neurodegenerative diseases and other disorders.
Where is PharmatrophiX headquartered?
PharmatrophiX is headquartered in Raleigh, US.
Which VCs invest in companies like PharmatrophiX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PharmatrophiX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PharmatrophiX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.